𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Continuous infusion of highly purified factor VIII (monoclate M)

✍ Scribed by Sanjeet Flora; Henry Hambley; Jill Thumpston; Jane Clark


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
122 KB
Volume
40
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Continuous infusion of porcine factor VI
✍ Rubinger, Morel; Houston, Donald S.; Schwetz, Nora; Woloschuk, Donna M. M.; Isra πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 178 KB πŸ‘ 2 views

The effectiveness of continuous infusion porcine factor VIII (PFVIII) has been evaluated in the treatment of 7 consecutive patients with factor VIII(FVIII) inhibitors. Two patients had hemophilia A and five were nonhemophiliacs with acquired FVIII inhibitors. The median pretreatment anti-porcine FVI

Viral safety of a new highly purified fa
✍ Biesert, Lothar; Lemon, Stanley; Goudeau, Alain; Suhartono, Haryadi; Wang, Lingr πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 666 KB

The inactivation of both transfusion-relevant and model viruses by modified pasteurisation (10 hours at 63Β°C in solution) has been evaluated following the established guidelines of the EU CPMP Ad Hoc Working Party on Biotechnology/ Pharmacy. This heat treatment was introduced into the manufacturing

In vitro factor VIII recovery during the
✍ DiMichele, Donna M.; Lasak, Martin E.; Miller, Connie H. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 397 KB πŸ‘ 2 views

Factor Vlll (FVIII) replacement by continuous infusion has been advocated as a costeffective method for maintaining stable plasma levels of FVlll in the hemophilia A patient during surgery or lifethreatening hemorrhage. Continuous delivery of monoclonal or recombinant FVlll concentrates to our pedia

Stability and sterility of a recombinant
✍ Belgaumi, Asim F.; Patrick, Christian C.; Deitcher, Steven R. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 2 views

## Minipumps may facilitate cost-effective and convenient continuous infusion (CI) therapy for severe hemophilia A. This study evaluated the in vitro sterility, ability to support bacterial growth, and specific activity stability of a recombinant factor VIII (FVIII; Bio-clateβ„’, Centeon) delivered